September 12, 2024

First 'movie' of influenza virus genome multiplication obtained

IMDEA Nanoscience researchers have observed, for the first time, the multiplication of the influenza A virus genome in real time. This fact will help to understand some of the factors that determine the speed of multiplication of this infectious microorganism.
September 11, 2024

The scientific journal 'Invasive Physiotherapy and Musculoskeletal Medicine' is born to promote research in invasive physiotherapy

The iHealthy group of the IIS Aragón presents a new international platform to disseminate advances in invasive physiotherapy and musculoskeletal medicine. The first article will be available in January 2025.
September 10, 2024

A yellow dye makes living animals transparent

By applying a food additive dissolved in water, US scientists have succeeded in making the skin on the skull and abdomen of mice translucent in a safe and reversible way. This advance could revolutionise optical research in biology and help in medical diagnosis if it is applied to humans in the future.
September 6, 2024

Drugs that regulate fatty acid metabolism could help in the treatment of pancreatic cancer in combination with chemotherapy

The Journal of Translational Medicine has published an article by Marta Mascaraque, researcher in the IIS Aragón 'Metabolism & Cancer Stem Cells' group, on fatty acid metabolism in pancreatic cancer.
September 5, 2024

The International Conference on Communication in Health (ICCH 2024) will take place from 9 to 13 September 2024 in Zaragoza

Among the national representatives at the Congress will be Rosa Magallón, a researcher at the IIS Aragón, who leads the Aragonese Primary Care Research Group (GAIAP).
September 4, 2024

José Ignacio Castaño Lasaosa: “Healthcare management should be considered as another medical specialization”

In this interview, the IIS Aragón researcher talks about his work leading the 'Innovation in Health Management and Health Economics' Group (GIISA005) and what his projects are like.
September 2, 2024

New study reveals the crucial role of LUBAC in LTβR signaling and its impact on liver cancer prognosis

Researchers from the UCL Cancer Institute (London), the University of Cologne, the IIS Aragón and the University of Stuttgart have made a revolutionary discovery in the field of cancer biology.
August 30, 2024

Learn about audiovisuals, writing and photography in free workshops from Paciente en Ciencia

Three new sessions of Patient in Science, the IIS Aragón project with the collaboration of FECYT that seeks to strengthen the interaction between citizens, patients and researchers.